Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Alison Sathe
Anders Vinther
Barbara W. Unger
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Mark Agostino
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Subscribe
Conference Spotlight

Inadequate Media Fills at a Sterile Manufacturer When Starting up After a Shutdown: CGMP Inspection Case Study by FDA National Drug Expert Ileana Barreto-Pettit

June 18, 2020
Redica Systems
No items found.
Conference Spotlight

Cleaning and Cross-contamination Issues with an Encapsulator: CGMP Inspection Case Study by FDA National Drug Expert Ileana Barreto-Pettit

June 11, 2020
Redica Systems
No items found.
Conference Spotlight

David Doleski Encourages Industry to Participate in FDA’s Emerging Technology Efforts; Sanofi Case Study Reviewed

June 9, 2020
Redica Systems
No items found.
Trends

What is Risk-Based Thinking?

June 4, 2020
Redica Systems
No items found.
Enforcement

FDA Warning Letters Week of 05/24/20: Sterile Drugs, OTC Products, & Hiring of Quality Consultants

June 2, 2020
Redica Systems
No items found.
Conference Spotlight

Former FDA Official David Doleski on Agency Hot Button Issues and Developing a Positive Relationship

May 28, 2020
Redica Systems
No items found.
Enforcement

Warning Letters Week of 5/17/20

May 26, 2020
Redica Systems
No items found.
Enforcement

Warning Letters Week of 5/3/2020: 42 Concern COVID-19 Claims

May 12, 2020
Redica Systems
No items found.
Conference Spotlight

Avoiding and Reacting to Human Tissue, Cell, and Gene Therapy Enforcement Actions: Communication is Key

May 7, 2020
Redica Systems
No items found.
Enforcement

FDA Warning Letters Week of 4/27/2020: HCT/P

May 6, 2020
Redica Systems
No items found.
Enforcement

Roundup of Q1 2020 Food and Dietary Supplement Warning Letters

April 29, 2020
Redica Systems
No items found.
Enforcement

Warning Letters Week of 4/20/2020: Untitled Letter to Stem Cell Firm

April 27, 2020
Redica Systems
No items found.

Part 2: Analysis of FDA FY2019 Drug GMP Warning Letters

April 23, 2020
Redica Systems
No items found.

Human Cell and Tissue Therapy Enforcement Actions Target Unapproved New Products Making Unsubstantiated Claims

April 23, 2020
Redica Systems
No items found.
Enforcement

Warning Letters Week of 4/13/2020: Compounding Pharmacy

April 21, 2020
Redica Systems
No items found.

Deploying Risk-Based Thinking within Management Systems

April 16, 2020
Redica Systems
No items found.
Enforcement

FDA Warning Letters Week of 4/6/2020: Devices, BIMO

April 14, 2020
Redica Systems
No items found.

March 483s: Most Popular and Newsworthy

April 9, 2020
Redica Systems
No items found.

Other Resources

Assessments

Insights on inspections, risk and compliance

Reports

Benchmark industry trends and best practices

Webinars

Hear from industry leaders and Redica experts.